The science on COVID-19 and type 2 diabetes continues to evolve rapidly. If you haven’t been able to keep up to date on our latest COVID-19 coverage, don’t fret. Virta Medical Director Dr. Sarah Hallberg summarizes some key topics in this presentation, including:
Why it is difficult to get a definitive scientific understanding of COVID-19
Type 2 diabetes as a risk factor for COVID-19, including a systematic review and meta-analysis
Obesity as a risk factor for COVID-19, including an examination of cases of requiring invasive mechanical ventilation
Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes
The latest on outcomes associated with use of Angiotensin-converting Enzyme Inhibitors (ACEI) and Angiotensin II Receptor Blockers (ARB)
We use cookies on our site to give you the best experience possible. By continuing to browse the site, you agree to this use. For more information on how we use cookies, see our Privacy Policy.